ArticleInvestigative ophthalmology & visual science2026
Tcf4 CTG Repeat Expansion Induces RNA Toxicity and MBNL-Associated Splicing Dysregulation in a Mouse Model of Fuchs Endothelial Corneal Dystrophy.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To determine whether a Tcf4 CTG repeat knock-in mouse model of Fuchs endothelial corneal dystrophy (FECD) recapitulates molecular features of repeat RNA toxicity and MBNL-associated splicing dysregulation in corneal endothelial cells in vivo. Methods: Corneal endothelial tissues from 20-, 40-, and 60-week-old wild-type and Tcf4(CTG)100/(CTG)100 mice were examined by contact specular microscopy and CUG-repeat RNA FISH with MBNL1 immunostaining. At 60 weeks, we used RT-PCR, quantitative PCR, Western blotting, and RNA-Seq analysis to assess Mbnl autoregulatory splicing, genome-wide alternative splicing, RNA-binding protein motif enrichment, and Tcf4 isoform composition; selected splicing events were compared with human FECD data. Results: Tcf4(CTG)100/(CTG)100 mice showed neither obvious guttae-like abnormalities nor nuclear RNA foci at 20 weeks; both were detected at 40 and 60 weeks, whereas wild-type mice showed neither at any age. Foci-positive nuclei and RNA foci-MBNL1 colocalization did not differ between 40 and 60 weeks. Although Mbnl1 and Mbnl2 transcript levels and MBNL1 and MBNL2 protein levels were unchanged, Mbnl2 exon 6 inclusion was reduced. RNA-Seq reanalysis identified 645 differential alternative splicing events, predominantly skipped exons, with MBNL1 motif enrichment among events with increased exon skipping. Representative MBNL-regulated events were only partially conserved between the mouse model and human FECD. Total Tcf4 expression was unchanged, whereas Tcf4-225 was selectively upregulated. Conclusions: This model provides in vivo evidence that Tcf4 CTG repeat expansion can induce molecular hallmarks of repeat RNA toxicity and downstream MBNL-associated splicing dysregulation, together with selective Tcf4 isoform alteration. It offers an in vivo platform for mechanistic and therapeutic studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.